A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Completed · Phase 2 · Has a placebo group

Conditions studied: Rhinovirus

In brief

This study aims to evaluate the safety, tolerability and effectiveness of BTA798 on * shortening the length and reducing the symptoms of human rhinovirus infection (also known as the common cold), * controlling asthma symptoms, and * lowering the risk of asthma symptoms worsening in subjects with asthma.

Key facts

Study ID

NCT01175226

Run by

Biota Scientific Management Pty Ltd

People needed

300

Starts

2010-08-01

Expected to finish

2012-03-01

Last updated by the study team

2018-05-31

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female subjects aged 18-70 years
• Diagnosis of asthma consistent with Global Initiative for Asthma (GINA) steps 1 to 3
• Presumptive human rhinovirus infection

You may not qualify if…

• Current severe asthma exacerbation
• Severe asthma, GINA steps 4 or higher
• Uncontrolled or clinically significant medical condition, disease or event which could impact subject safety and/or study evaluations and/or compliance to the protocol
• Current smoker, ex-smoker of <1 year, or history of smoking >/=10 pack years.

Where it is running

• Research Site — Scottsdale, Arizona, United States
• Research Site — Little Rock, Arkansas, United States
• Research Site — Fountain Valley, California, United States
• Research Site — Orange, California, United States
• Research Site — Waterbury, Connecticut, United States
• Research Site — Hialeah, Florida, United States
• Research Site — Bangor, Maine, United States
• Research Site — Baltimore, Maryland, United States
• Research Site — Bethesda, Maryland, United States
• Research Site — Boston, Massachusetts, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Papillion, Nebraska, United States
• Research Site — Albuquerque, New Mexico, United States
• Research Site — New York, New York, United States
• Research Site — Newburgh, New York, United States
• Research Site — North Syracuse, New York, United States
• Research Site — Rockville Centre, New York, United States
• Research Site — Asheville, North Carolina, United States
• Research Site — Raleigh, North Carolina, United States
• Research Site — Fargo, North Dakota, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.